Clinical Trials Logo

Clinical Trial Summary

The aim of the CORONA.BOT project is to exploit the Artificial Intelligence methods of Generator Real World Data Facility to automatically extract structured and unstructured data from hospital databases and to implement an early risk assessment (warning system) regarding the negative outcome for patients infected with SARS-CoV-2. The objective of CORONABED.BOT is to analyze the care pathways of patients from the same cohort as CORONA.BOT, in order to identify the total length of stay, intensive care occupations and flows between departments, based on variables demographics and first entry clinics Early identification of patients with symptoms compatible with SARS-CoV-2 infection will enable more rapid activation of isolation procedures, contact monitoring/contact history and decisions on the most appropriate clinical pathway in terms of type of treatment and unit. Similarly, the identification of factors correlated with worse outcomes will allow more effective planning for the use of critical resources (such as intensive care and others).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Severe Acute Respiratory Syndrome

NCT number NCT05787405
Study type Observational
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact rita murri
Phone 003090630154945
Email rita.murri@policlinicogemelli.it
Status Recruiting
Phase
Start date December 1, 2020
Completion date December 30, 2025